This proposal will investigate the role of oxalate in the pathogenesis of kidney stone disease. A central tenet of our research over the past several years has been that tubular damage/or dysfunction plays a crucial role in the retention of calcium oxalate crystals within the kidney, with damaged cells serving either as sources of membraneous debris for crystal nucleation or binding, and/or as sites for crystal adherence. Our recent studies have demonstrated that oxalate damages renal epithelial by process(es) involving reactive oxygen molecules. Moreover, oxalate toxicity was observed within the range of concentrations that occur normally in urine. Other studies demonstrated effects of oxalate on the proliferation of renal epithelial cells. Thus oxalate may exert dual effects on the viability and growth of renal cells. The present proposal will examine these effects of oxalate and their possible role in kidney stone disease by addressing the following: 1) How does oxalate induce damage to renal tubular cells? Are the effects due to increased production of peroxyl radicals, decreased glutathione, increase lipid peroxidation, and/or alterations in Ca2+i or pHi? 2) Does oxalate stimulate cell proliferation or does the increase in DNA synthesis reflect DNA repair or a prelude to apoptosis? Are these responses also mediated by free radicals? 3) Are the effects of oxalate selective for proximal tubular cells (LLC-PK1 cells) or can we observe similar changes in distal tubular cells (MDCK cells) and/or in inner medullary collecting duct cells (primary cultures)? 4) Can we detect similar oxalate induced changes in viability and growth in renal tubular cells from stone-forming animals? 5) Can we reduce oxalate toxicity by genetic manipulations (transfection with the oxalate oxidase gene to promote oxalate degradation or with the bcl-2 gene to protect against oxidant stress)? Such studies will provide valuable knowledge of specific oxalate-induced changes in renal epithelial cell function and insight as to how such changes might contribute to stone formation. Understanding the cellular basis for oxalate action should provide the basis for new strategies in the prevention and management of urolithiasis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043184-08
Application #
2634225
Study Section
Surgery, Anesthesiology and Trauma Study Section (SAT)
Project Start
1991-01-01
Project End
1999-06-30
Budget Start
1998-01-15
Budget End
1999-06-30
Support Year
8
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Massachusetts Medical School Worcester
Department
Physiology
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655
Jonassen, Julie A; Kohjimoto, Yasuo; Scheid, Cheryl R et al. (2005) Oxalate toxicity in renal cells. Urol Res 33:329-39
Cao, Lu-Cheng; Honeyman, Thomas W; Cooney, Rachel et al. (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66:1890-900
Scheid, Cheryl R; Cao, Lu-Cheng; Honeyman, Thomas et al. (2004) How elevated oxalate can promote kidney stone disease: changes at the surface and in the cytosol of renal cells that promote crystal adherence and growth. Front Biosci 9:797-808
Jonassen, Julie A; Cao, Lu-Cheng; Honeyman, Thomas et al. (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13:55-72
Cao, L C; Jonassen, J; Honeyman, T W et al. (2001) Oxalate-induced redistribution of phosphatidylserine in renal epithelial cells: implications for kidney stone disease. Am J Nephrol 21:69-77
Zhao, G; Monier-Faugere, M C; Langub, M C et al. (2000) Targeted overexpression of insulin-like growth factor I to osteoblasts of transgenic mice: increased trabecular bone volume without increased osteoblast proliferation. Endocrinology 141:2674-82
Cao, L C; Honeyman, T; Jonassen, J et al. (2000) Oxalate-induced ceramide accumulation in Madin-Darby canine kidney and LLC-PK1 cells. Kidney Int 57:2403-11
Scheid, C; Honeyman, T; Kohjimoto, Y et al. (2000) Oxalate-induced changes in renal epithelial cell function: role in stone disease. Mol Urol 4:371-82
Miller, C; Kennington, L; Cooney, R et al. (2000) Oxalate toxicity in renal epithelial cells: characteristics of apoptosis and necrosis. Toxicol Appl Pharmacol 162:132-41
Kohjimoto, Y; Honeyman, T W; Jonassen, J et al. (2000) Phospholipase A2 mediates immediate early genes in cultured renal epithelial cells: possible role of lysophospholipid. Kidney Int 58:638-46

Showing the most recent 10 out of 22 publications